Apellis Pharmaceuticals, Inc.
NasdaqGS:APLS
Sector
Location
Market Cap
USD 2.39 B
Share Price
USD 19.00
Avg Daily Volume
2,459,340
Change (1 day)
0.26%
Change (1 year)
-51.57%
Change (YTD)
-40.46%
Apellis Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -8.29 M
Apellis Pharmaceuticals, Inc. Operating Cash Flow is USD -8.29 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -98.49% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Apellis Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -550.10 M, a -5.12% change year over year.
-
Apellis Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -579.80 M, a 11.21% change year over year.
-
Apellis Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -521.37 M, a 153.77% change year over year.
-
Apellis Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -205.45 M, a -27.64% change year over year.
StockViz
Competitors
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Moderna, Inc.
USD 32.15
MRNA
-0.51
-1.56%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
+0.03
0.43%
Swedish Orphan Biovitrum AB (publ)
USD 28.44
SOBI.ST
-2.22
-7.23%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.45
300122.SZ
+0.01
0.41%
Ionis Pharmaceuticals, Inc.
USD 43.37
IONS
+1.89
4.56%
Rhythm Pharmaceuticals, Inc.
USD 84.66
RYTM
-0.97
-1.13%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.37
1877.HK
-0.02
-0.55%
Vaxcyte, Inc.
USD 34.82
PCVX
+0.14
0.40%
Hualan Biological Engineering Inc.
USD 2.33
002007.SZ
-0.01
-0.31%
Bavarian Nordic A/S
USD 35.99
BAVA.CO
-0.58
-1.58%
NewAmsterdam Pharma Company N.V.
USD 22.43
NAMS
-0.35
-1.54%
Ligand Pharmaceuticals Incorporated
USD 135.23
LGND
+3.65
2.77%
Apogee Therapeutics, Inc.
USD 37.61
APGE
-0.32
-0.84%
ARS Pharmaceuticals, Inc.
USD 17.88
SPRY
+0.13
0.73%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Moderna, Inc.
USD 32.15
MRNA
-0.51
-1.56%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
+0.03
0.43%
Swedish Orphan Biovitrum AB (publ)
USD 28.44
SOBI.ST
-2.22
-7.23%
Chongqing Zhifei Biological Products Co., Ltd.
USD 3.45
300122.SZ
+0.01
0.41%
Ionis Pharmaceuticals, Inc.
USD 43.37
IONS
+1.89
4.56%
Rhythm Pharmaceuticals, Inc.
USD 84.66
RYTM
-0.97
-1.13%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.37
1877.HK
-0.02
-0.55%
Vaxcyte, Inc.
USD 34.82
PCVX
+0.14
0.40%
Hualan Biological Engineering Inc.
USD 2.33
002007.SZ
-0.01
-0.31%
Bavarian Nordic A/S
USD 35.99
BAVA.CO
-0.58
-1.58%
NewAmsterdam Pharma Company N.V.
USD 22.43
NAMS
-0.35
-1.54%
Ligand Pharmaceuticals Incorporated
USD 135.23
LGND
+3.65
2.77%
Apogee Therapeutics, Inc.
USD 37.61
APGE
-0.32
-0.84%
ARS Pharmaceuticals, Inc.
USD 17.88
SPRY
+0.13
0.73%